The invention relates to a method for the treatment of tuberculosis comprising administering to a subject in need thereof a therapeutically effective amount of the compound of Formula 1 (as provided in the description) or a stereoisomer a tautomer pharmaceutically acceptable salts thereof or derivatives thereof such as esters and ethers. The invention further relates to a pharmaceutical composition comprising the compound of Formula 1 and at least one pharmaceutically acceptable carrier for use in the treatment of tuberculosis.
